M. Clerici

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.

M. Clerici, U. Veronesi, G. Palo, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

F. Zunino, R. Supino, F. Formelli, 1996, International journal of cancer.

Retinoids: in vitro interaction with retinol‐binding protein and influence on plasma retinol

F. Formelli, G. Malpeli, R. Berni, 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

pml/RAR alpha protein leukemia cell line NB4 is associated with altered expression of the Occurrence of resistance to retinoic acid in the acute promyelocytic

G. Sozzi, F. Formelli, C. Nervi, 2011 .

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein.

P. Pelicci, G. Sozzi, F. Formelli, 1993, Blood.

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results.

L. Mariani, M. Clerici, U. Veronesi, 1992, European journal of cancer. Part B, Oral oncology.

Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration.

U. Veronesi, F. Formelli, G. D. De Palo, 1991, Annals of Oncology.

UV-A and UV-B Can Neutralize SARS-CoV-2 Infectivity

G. Pareschi, C. Tacchetti, A. Loffreda, 2021, medRxiv.